Galimedix Therapeutics Inc
2 clinical trials · Sponsor
◉ Watch Galimedix Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD (NCT06659549) | Galimedix Therapeutics Inc | 2025-01-10 |
| A SINGLE CENTER, 5-PART STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF GAL-101 SALT IN HEALTHY ADULT AND ELDERLY PARTICIPANTS (NCT07780604) | Galimedix Therapeutics Inc | 2024-11-18 |
Track Galimedix Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.